There was evidence of a larger association of genetically proxied GIP signalling compared with genetically proxied reduced type 2 diabetes liability more generally for CRP, HDL-C and triacylglycerol levels (all p < 0.001), but not strongly for BMI (p = 0.07, ESM Table 4). This evidence concerns the gene GIP and type 2 diabetes mellitus.